Science
Mechanism of Action
As a synthetic prostaglandin analog, Ethyl Tafluprostamide operates by first entering cells via a specific prostaglandin transporter (PGT) due to its lipophilic properties. Once inside, it engages and binds to G-protein coupled receptors (GPCRs), which are instrumental in mediating cellular responses by activating or inhibiting enzymes, triggering downstream physiological effects. This mechanism is known to promote eyelash growth and is also linked to the regulation of intraocular pressure.
Research
Clinical Evidence
Low confidence0.018%
Key findings
- 01 An in vitro percutaneous absorption study on human skin demonstrated 6.51% ± 2.16% absorption when applied at a 0.018% concentration.
- 02 A Human Repeat Insult Patch Test (HRIPT) involving 51 panelists showed no skin irritation at a concentration of 0.025%.
- 03 Both in vitro (EpiOcularTM RhCE assay, HET-CAM assay) and in vivo studies (daily use for 28 days in an eyelash product at 0.018% or 0.025%) reported no ocular irritation.
- 04 Commercial eyelash growth serums typically contain Ethyl Tafluprostamide in concentrations ranging from 0.0018% to 0.0176%. Cosmetic manufacturers have sought approval for a maximum concentration of 0.018% in cosmetic products within the EU Commission.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This ingredient exhibits hygroscopic properties, necessitating storage in a tightly sealed container. It should be maintained in a cool (2-8°C), dry, and well-ventilated environment, away from heat, sparks, and flame, and ideally stored under an inert gas atmosphere to preserve its integrity.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) currently deems the available data insufficient for a formal safety review, noting significant data gaps. Similarly, the Scientific Committee on Consumer Safety (SCCS) has been unable to conclude on its safety at intended cosmetic concentrations, such as 0.018%, citing concerns regarding the potent pharmacological activity of prostaglandin analogues and their use near the eye. Furthermore, the FDA often regulates products making efficacy claims related to prostaglandin analogs as drugs. Users should be aware that common or very common side effects associated with prostaglandin analogs include ocular discoloration, discomfort, inflammation, and disorders, as well as headaches, hypertension, hypertrichosis, skin reactions, and vision disturbances.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to insufficient safety data from regulatory bodies like CIR and SCCS, coupled with concerns regarding its potent pharmacological activity and potential for drug-like regulation, Ethyl Tafluprostamide's use in cosmetics carries significant regulatory and safety questions.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources